Christopher A. Lucchesi

555 total citations
21 papers, 414 citations indexed

About

Christopher A. Lucchesi is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Christopher A. Lucchesi has authored 21 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Oncology. Recurrent topics in Christopher A. Lucchesi's work include Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (3 papers) and RNA Research and Splicing (3 papers). Christopher A. Lucchesi is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (3 papers) and RNA Research and Splicing (3 papers). Christopher A. Lucchesi collaborates with scholars based in United States, Australia and Italy. Christopher A. Lucchesi's co-authors include William Healy, David Appleby, David W. Lemos, Khaled J. Saleh, Xinbin Chen, Jin Zhang, M. Saeed Sheikh, Ying Huang, Mingyi Chen and Buyong Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Christopher A. Lucchesi

21 papers receiving 403 citations

Peers

Christopher A. Lucchesi
Christopher A. Lucchesi
Citations per year, relative to Christopher A. Lucchesi Christopher A. Lucchesi (= 1×) peers Joannes A. A. Reijers

Countries citing papers authored by Christopher A. Lucchesi

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Lucchesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Lucchesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Lucchesi more than expected).

Fields of papers citing papers by Christopher A. Lucchesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Lucchesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Lucchesi. The network helps show where Christopher A. Lucchesi may publish in the future.

Co-authorship network of co-authors of Christopher A. Lucchesi

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Lucchesi. A scholar is included among the top collaborators of Christopher A. Lucchesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Lucchesi. Christopher A. Lucchesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jin, Hee Jung Yang, Shakur Mohibi, et al.. (2024). Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion. Cancers. 16(1). 229–229. 1 indexed citations
2.
Lucchesi, Christopher A., Jin Zhang, Mingchun Gao, Jared T. Shaw, & Xinbin Chen. (2023). Identification of a First-in-Class Small-Molecule Inhibitor of the EIF4E-RBM38 Complex That Enhances Wild-type TP53 Protein Translation for Tumor Growth Suppression. Molecular Cancer Therapeutics. 22(6). 726–736. 5 indexed citations
3.
Lucchesi, Christopher A., et al.. (2023). Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies. International Journal of Molecular Sciences. 24(14). 11395–11395. 7 indexed citations
4.
Siddiqui, Salma, Christopher A. Lucchesi, Benjamin A. Mooso, et al.. (2023). Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer. Scientific Reports. 13(1). 9617–9617. 7 indexed citations
5.
Lucchesi, Christopher A., et al.. (2023). Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants. Biomedicines. 11(4). 1100–1100. 4 indexed citations
6.
Lucchesi, Christopher A., et al.. (2022). Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression. Frontiers in Oncology. 12. 893062–893062. 2 indexed citations
7.
Toedebusch, Ryan G., et al.. (2022). Microglia-Derived Olfactomedin-like 3 Is a Potent Angiogenic Factor in Primary Mouse Brain Endothelial Cells: A Novel Target for Glioblastoma. International Journal of Molecular Sciences. 23(23). 14613–14613. 3 indexed citations
8.
Lucchesi, Christopher A., Jin Zhang, Buyong Ma, Ruth Nussinov, & Xinbin Chen. (2021). Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a. Cancer Research. 81(7). 1827–1839. 5 indexed citations
9.
Toedebusch, Ryan G., et al.. (2021). Microglia-Derived Olfactomedin-like 3 Promotes Pro-Tumorigenic Microglial Function and Malignant Features of Glioma Cells. International Journal of Molecular Sciences. 22(23). 13052–13052. 8 indexed citations
10.
Lee, Adrian Y. S., Dimitra Beroukas, Christopher A. Lucchesi, et al.. (2020). Identification of a unique anti-Ro60 subset with restricted serological and molecular profiles. Clinical & Experimental Immunology. 203(1). 13–21. 10 indexed citations
11.
Lucchesi, Christopher A., Jin Zhang, Buyong Ma, Mingyi Chen, & Xinbin Chen. (2018). Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression. Cancer Research. 79(4). 807–818. 34 indexed citations
12.
Dolan, Robert W., et al.. (2017). Results, Knowledge, and Attitudes Regarding an Incentive Compensation Plan in a Hospital-Based, Academic, Employed Physician Multispecialty Group. Journal of Healthcare Management. 62(2). 120–133. 4 indexed citations
13.
Yang, Hee Jung, Jin Zhang, Wensheng Yan, et al.. (2017). Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner. Proceedings of the National Academy of Sciences. 114(43). 11500–11505. 42 indexed citations
14.
Lucchesi, Christopher A., Jin Zhang, & Xinbin Chen. (2016). Modulation of the p53 family network by RNA-binding proteins. Translational Cancer Research. 5(6). 676–684. 11 indexed citations
15.
Michaud, Michael, Gaëlle Pérot, Tom Lesluyes, et al.. (2016). The emerging role of ATRX and chromatin remodeling in pleomorphic sarcomas oncogenesis. European Journal of Cancer. 61. S28–S28. 1 indexed citations
16.
Lucchesi, Christopher A., M. Saeed Sheikh, & Ying Huang. (2015). Negative regulation of RNA-binding protein HuR by tumor-suppressor ECRG2. Oncogene. 35(20). 2565–2573. 26 indexed citations
17.
Sun, Hong‐Wei, Lingyan Jiang, Xuelian Luo, et al.. (2012). Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer. Oncogene. 32(2). 234–241. 42 indexed citations
18.
Healy, William, et al.. (2001). Displaced Femoral Neck Fractures in the Elderly. Clinical Orthopaedics and Related Research. 383(383). 229–242. 151 indexed citations
19.
Healy, William, et al.. (1998). Opportunities for control of hospital costs for total joint arthroplasty after initial cost containment. The Journal of Arthroplasty. 13(5). 504–507. 44 indexed citations
20.
Iorio, Richard, W L Healy, David W. Lemos, David Appleby, & Christopher A. Lucchesi. (1998). Displaced femoral neck fractures in the elderly: Methods of treatment with analysis of outcomes and cost effectiveness. The Journal of Arthroplasty. 13(2). 230–230. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026